Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-κB Inhibition.
published in: Journal of Pharmacology and Experimental Therapeutics
date of publication: 2017-04-27
language: English
main subject: lipopolysaccharide, NF-κB, neuronitis
Cites articles
There is nothing here
Article - wd:Q38705775